# Naropin

NDC: 63323-287
Generic name: ROPIVACAINE HYDROCHLORIDE
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, PERINEURAL
Marketing started: 19960924

FDA application: NDA020533

## Active ingredients

- ROPIVACAINE HYDROCHLORIDE: 7.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-287"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-287
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=23d2d448-a744-4877-9f2d-7e57c198da89